Literature DB >> 4582382

Some actions of growth hormone release inhibiting factor.

A P Hansen, H Orskov, K Seyer-Hansen, K Lundbaek.   

Abstract

Preliminary studies indicate that somatostatin (SRIF, somatropin release inhibiting factor) can suppress exercise-induced plasma growth hormone rise in normal subjects as well as in diabetics.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4582382      PMCID： PMC1586974          DOI： 10.1136/bmj.3.5879.523

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  2 in total

1.  The effect of adrenergic receptor blockade on the exercise-induced serum growth hormone rise in normals and juvenile diabetics.

Authors:  A P Hansen
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

2.  Diabetes, diabetic angiopathy, and growth hormone.

Authors:  K Lundbaek; N J Christensen; V A Jensen; K Johansen; T S Olsen; A P Hansen; H Orskov; R Osterby
Journal:  Lancet       Date:  1970-07-18       Impact factor: 79.321
  2 in total
  13 in total

1.  Effects of synthetic somatostatin on endotoxin-induced changes of growth hormone, cortisol and insulin in plasma, blood sugar and blood leukocytes in man.

Authors:  H Wagner; E Zierden; W H Hauss
Journal:  Klin Wochenschr       Date:  1975-06-01

2.  The mechanism whereby growth hormone-release inhibiting hormone (somatostatin) inhibits food stimulated gastric acid secretion in the cat.

Authors:  M Albinus; E L Blair; E R Grund; J D Reed; D J Sanders; A Gomez-Pan; A V Schally; G M Besser
Journal:  Agents Actions       Date:  1975-10

3.  Beta cell nesidioblastosis.

Authors:  K Becker; U Wendel; H Przyrembel; M Tsotsalas; H Münterfering; H J Bremer
Journal:  Eur J Pediatr       Date:  1978-01-17       Impact factor: 3.183

Review 4.  Somatostatin--both hormone and neurotransmitter?

Authors:  R Luft; S Efendić; T Hökfelt
Journal:  Diabetologia       Date:  1978-01-14       Impact factor: 10.122

5.  An electroencephalographic investigation of short-term effects of three hypothalamic hormones (TRH, LH/FSH-RH, GH-RIH) in normal subjects.

Authors:  H Ashton; J E Millman; R Telford; J W Thompson; T F Davies; R Hall
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

6.  [Influence of somatastatin on oral glucose tolerance in autonomous hypersecretion of growth hormone, prolactin or insulin (author's transl)].

Authors:  M Gottsmann; R Landgraf; W Londong; K Werder
Journal:  Klin Wochenschr       Date:  1975-12-15

7.  Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.

Authors:  J E Gerich; M Lorenzi; D M Bier; E Tsalikian; V Schneider; J H Karam; P H Forsham
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

8.  Effect of somatostatin on metabolic and hormonal changes induced by nicotinic acid in insulin-dependent diabetics.

Authors:  A S Luyckx; P J Lefebvre
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122

9.  Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.

Authors:  N Faure; J H Dussault; A Nadeau; F Szots; H Guyda; F Labrie
Journal:  Can Med Assoc J       Date:  1977-09-03       Impact factor: 8.262

10.  An in vivo model for testing somatostatin suppression of growth hormone release in sheep.

Authors:  C Redekopp; L D Barrier; J H Livesey; R A Donald
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.